Google DeepMind has launched AlphaProteo, an AI system that helps researchers design high-strength proteins that bind accurately to target molecules. Trained on the Protein Data Bank, AlphaProteo creates candidate proteins based on the structure of a target molecule and binding locations. It has shown success in designing protein binders for various targets, including those associated with cancer and viral infections. Despite its breakthroughs, AlphaProteo has limitations and ongoing efforts are focused on improving its capabilities. Google has also released other AI technologies, such as Tx-LLM for drug discovery. The company continues to collaborate with healthcare organizations to leverage AI in medical research and information processing.
Source link
Google DeepMind unveils AlphaProteo for AI drug design
